FDA Advisory Committees Need Better Conflict Of Interest Procedures – NEJM
Executive Summary
FDA should publish the names and background information of proposed advisory committee members in advance of scheduled meetings, a New England Journal of Medicine editorial recommends
You may also be interested in...
Medical Journals Need Taste Of Their Own Medicine, FDA’s Gottlieb Says
Medical journals need to take measures to expedite providing up-to-date information to physicians, FDA Deputy Commissioner for Scientific & Regulatory Affairs Scott Gottlieb said
Medical Journals Need Taste Of Their Own Medicine, FDA’s Gottlieb Says
Medical journals need to take measures to expedite providing up-to-date information to physicians, FDA Deputy Commissioner for Scientific & Regulatory Affairs Scott Gottlieb said
New FDA Conflict Of Interest Policy Enacted At MT 100 Committee Meeting
FDA's new conflict-of-interest disclosure policy for advisory committee members was inaugurated at the Aug. 4 Peripheral & Central Nervous System Drugs Advisory Committee meeting